Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Drug Tolerance”

302 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 302 results

Not applicableStudy completedNCT03194100
What this trial is testing

Serum METRNL Concentration in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Chungnam National University Hospital 125
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06797310
What this trial is testing

Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study

Who this might be right for
Alopecia Areata
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT02055521
What this trial is testing

Search Tolerance Signature in Vascularised Composite Allograft

Who this might be right for
Hand and Face Allotransplantation
Hospices Civils de Lyon 18
Not applicableUnknownNCT05772507
What this trial is testing

Efficacy and Tolerance of URGO AWC_008 and URGO AWC_022 Dressings (EXPANSION)

Who this might be right for
Diabetic Foot UlcerVenous Leg UlcerPressure Ulcer+2 more
Laboratoires URGO 85
Early research (Phase 1)Ended earlyNCT02110563
What this trial is testing

Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma

Who this might be right for
Solid TumorsMultiple MyelomaNon-Hodgkins Lymphoma+3 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 50
Testing effectiveness (Phase 2)UnknownNCT05468229
What this trial is testing

Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT

Who this might be right for
Glucose Intolerance
Chinese University of Hong Kong 20
Testing effectiveness (Phase 2)Looking for participantsNCT06679036
What this trial is testing

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Who this might be right for
Advanced Unresectable or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd. 300
Not applicableStudy completedNCT00002272
What this trial is testing

An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

Who this might be right for
Herpes SimplexHIV Infections
Astra USA
Not applicableStudy completedNCT05869344
What this trial is testing

Black Bean (Phaseolus Vulgaris L.) Protein Hydrolysates Reduce Acute Postprandial Glucose Levels

Who this might be right for
PreDiabetes
Claudia Luévano-Contreras 28
Early research (Phase 1)Ended earlyNCT00282412
What this trial is testing

Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism

Who this might be right for
Rheumatoid Arthritis
Northwestern University 4
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Early research (Phase 1)Study completedNCT02620293
What this trial is testing

A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin

Who this might be right for
Eczema
Reckitt Benckiser Healthcare (UK) Limited 33
Not applicableStudy completedNCT00849758
What this trial is testing

Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer Patients

Who this might be right for
Breast CancerElderly
Universitaire Ziekenhuizen KU Leuven 110
Not applicableStudy completedNCT03172364
What this trial is testing

To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin

Who this might be right for
Skin Care
GlaxoSmithKline 122
Early research (Phase 1)Study completedNCT04539340
What this trial is testing

A Multi-cohort Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 20
Not applicableUnknownNCT05510466
What this trial is testing

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis

Who this might be right for
Metastatic Melanoma
University Hospital, Montpellier 18
Large-scale testing (Phase 3)Ended earlyNCT00543127
What this trial is testing

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 870
Testing effectiveness (Phase 2)Study completedNCT00469235
What this trial is testing

Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars

Who this might be right for
Keloid
Renovo 20
Next Page